Praxis Investment Management Inc. Purchases 3,541 Shares of Danaher Corporation $DHR

Praxis Investment Management Inc. boosted its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 12.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,406 shares of the conglomerate’s stock after acquiring an additional 3,541 shares during the period. Praxis Investment Management Inc.’s holdings in Danaher were worth $5,955,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of DHR. Norges Bank purchased a new position in shares of Danaher during the 4th quarter valued at $2,177,106,000. Viking Global Investors LP raised its position in shares of Danaher by 543.9% in the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after buying an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Danaher by 104.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after buying an additional 2,216,789 shares in the last quarter. Wellington Management Group LLP boosted its stake in Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after buying an additional 1,517,904 shares during the period. Finally, Capital International Investors grew its position in Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after buying an additional 1,487,768 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of Danaher stock opened at $197.85 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a fifty day moving average of $179.01 and a 200-day moving average of $200.54. The stock has a market capitalization of $140.03 billion, a price-to-earnings ratio of 38.27, a price-to-earnings-growth ratio of 2.52 and a beta of 0.79.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the company earned $1.88 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is 30.95%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on DHR. Morgan Stanley lowered their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Barclays decreased their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Piper Sandler started coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. Evercore raised their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Finally, Citigroup initiated coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $233.61.

View Our Latest Stock Report on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.